 |
SYDNEY, June 17, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that the United States Food and Drug Administration (FDA) has awarded Orphan Drug Designation (ODD) to Kazia's paxalisib for the treatment of atypical rhabdoid / teratoid tumors (AT/RT), a...
Hashtag.net.au
Dental emergencies rarely arrive with a polite warning. They burst in like an unexpected storm, bringing pain, discomfort, and urgency. In such moments, having access to a reliable emergency dental ...
Hashtag.net.au
For many Australians living with significant disability, the question of where to live — and how to live there safely and comfortably — is one of the most important and most complex they will ever f...
Hashtag.net.au
If you're running a construction site, a civil project, or a trade-based operation anywhere in Australia, first aid preparedness probably sits somewhere near the bottom of your planning checklist — ...